Clinical Trial Update: Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of dimethyl fumarate in patients with mild cognitive impairment and dementia due to Alzheimer's diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Medical University of Lodz | Conditions: MCI, MCI-AD, Early Stage Alzheimer's Disease | Phase 2 | Status: RECRUITING